Hyperparathyroïdie et ostéoporose
Authors:
- 1 December 2004
- journal article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 25, S560-S567
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Potential Clinical Utility of a New IRMA for Parathyroid Hormone in Postmenopausal Patients with Primary HyperparathyroidismClinical Chemistry, 2004
- “Incipient” Primary Hyperparathyroidism: A “Forme Fruste” of an Old DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2003
- Normocalcemic Primary Hyperparathyroidism: Evidence for a Generalized Target-Tissue Resistance to Parathyroid HormoneThe Journal of Clinical Endocrinology & Metabolism, 2003
- Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1–84) in Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2003
- The Use in Clinical Practice of Parathyroid Hormone Normative Values Established in Vitamin D-Sufficient SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2003
- The effects of vitamin D insufficiency in patients with primary hyperparathyroidismThe American Journal of Medicine, 1999
- IMPROVEMENTS IN PARATHYROID SURGERY IN THE INTACT 1–84 PTH ASSAY ERAAnz Journal of Surgery, 1998
- Primary hyperparathyroidism: Biochemical markers and bone mineral density at multiple skeletal sites in Danish patientsBone, 1997
- Primary hyperparathyroidismThe Lancet, 1997
- Vitamin D status in primary hyperparathyroidism in IndiaClinical Endocrinology, 1995